Terug
Dagbereik
€ 46,75
€ 48,67
52-Weeksbereik
€ 13,22
€ 94,90
Volume
767.602
50D / 200D Gem.
€ 71,72
/
€ 40,61
Vorige Slotkoers
€ 49,06
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -19,2 | 0,4 |
| P/B | 1,8 | 2,9 |
| ROE % | -11,9 | 3,9 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 116,71
+148.1%
Low: € 90,00
High: € 145,00
Forward WPA
-€ 1,72
Omzet Sch.
7,14M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 1,60
€ 1,60 – € 1,60
|
854,11M | 2 |
| FY2029 |
-€ 0,31
-€ 0,31 – -€ 0,31
|
632,55M | 4 |
| FY2028 |
-€ 1,91
-€ 4,04 – € 1,24
|
213,03M | 6 |
No quarterly estimates available
Dividend History
Yield
0,00%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Belangrijkste Punten
Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -225,81M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-11,86%
ROIC-14,16%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
0,00
Current Ratio24,81
Interest Coverage0,00
Waardering
P/E Ratio
-19,18
Forward P/EN/A
P/B Ratio1,79
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -141,20M |
| ROE | -11,86% | ROA | -8,91% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -225,81M |
| ROIC | -14,16% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 24,81 |
| Interest Coverage | 0,00 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -19,18 | Forward P/E | N/A |
| P/B Ratio | 1,79 | P/S Ratio | N/A |
| PEG Ratio | -11,37 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -8,34% | ||
| Market Cap | 2,71B | Enterprise Value | 1,91B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -141,20M | -122,53M | -89,62M | -51,32M | -40,01M |
| EPS (Diluted) | -2,40 | -2,34 | -2,43 | -1,44 | -1,20 |
| Gross Profit | -3,90M | 0,0 | 0,0 | 0,0 | 0,0 |
| Operating Income | -287,57M | -158,23M | -102,78M | -52,56M | -37,70M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,58B | 903,33M | 482,02M | 97,85M | 111,16M |
| Total Liabilities | 67,54M | 38,49M | 29,05M | 212,99M | 175,89M |
| Shareholders' Equity | 1,52B | 864,84M | 452,97M | -115,14M | -64,74M |
| Total Debt | 6,49M | 3,86M | 5,45M | 260.000,0 | 621.000,0 |
| Cash & Equivalents | 799,62M | 169,51M | 129,79M | 26,09M | 105,31M |
| Current Assets | 1,57B | 891,21M | 473,61M | 93,09M | 109,25M |
| Current Liabilities | 63,29M | 36,02M | 24,74M | 13,01M | 8,66M |